Title |
A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
|
---|---|
Published in |
Leukemia, August 2019
|
DOI | 10.1038/s41375-019-0539-0 |
Pubmed ID | |
Authors |
Thierry Facon, Meletios A. Dimopoulos, Nathalie Meuleman, Andrew Belch, Mohamad Mohty, Wen-Ming Chen, Kihyun Kim, Elena Zamagni, Paula Rodriguez-Otero, William Renwick, Christian Rose, Adrian Tempescul, Eileen Boyle, Salomon Manier, Michel Attal, Philippe Moreau, Margaret Macro, Xavier Leleu, Marie Lorraine Chretien, Heinz Ludwig, Shien Guo, Michael Sturniolo, Antoine Tinel, Mara Silvia Monzini, Bruno Costa, Vanessa Houck, Cyrille Hulin, Jean Yves Mary |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 55% |
Brazil | 1 | 9% |
Japan | 1 | 9% |
Algeria | 1 | 9% |
Unknown | 2 | 18% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 6 | 55% |
Members of the public | 4 | 36% |
Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 109 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 18% |
Other | 14 | 13% |
Student > Master | 9 | 8% |
Student > Bachelor | 7 | 6% |
Student > Ph. D. Student | 6 | 6% |
Other | 13 | 12% |
Unknown | 40 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 35 | 32% |
Biochemistry, Genetics and Molecular Biology | 6 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Nursing and Health Professions | 3 | 3% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 17 | 16% |
Unknown | 41 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2023.
All research outputs
#732,606
of 24,410,879 outputs
Outputs from Leukemia
#118
of 5,291 outputs
Outputs of similar age
#16,124
of 346,722 outputs
Outputs of similar age from Leukemia
#3
of 62 outputs
Altmetric has tracked 24,410,879 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,291 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,722 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.